☆ 4.7 Article

Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study

FRONTIERS IN PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Geriatrics & Gerontology

Continued potassium supplementation use following loop diuretic discontinuation in older adults: An evaluation of a prescribing cascade relic

Grace Hsin-Min Wang et al.

Summary: Based on the analysis of Medicare data, we found that it is common for older adults to receive potassium supplementation simultaneously or after loop diuretic initiation, and some patients continue to use potassium even after discontinuing the loop diuretic. This phenomenon, known as relics, highlights the need for clinicians to be aware of and address unnecessary drug use.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Improving the specificity of drug-drug interaction alerts: Can it be done?

Thomas Reese et al.

Summary: Inaccurate and nonspecific medication alerts can lead to high override rates, alert fatigue, and patient harm. This study highlights the inconsistency of drug value sets that trigger DDI alerts and demonstrates a method of classifying risk-modifying factors to improve alert specificity.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2022)

Add to Collection

Article Medicine, General & Internal

Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis

Surapon Nochaiwong et al.

Summary: This systematic review and meta-analysis found that the use of serotonin reuptake inhibitor (SRI) antidepressants in patients receiving antithrombotic therapy is associated with a higher risk of bleeding complications, including major bleeding, gastrointestinal bleeding, and any bleeding events. The risk is elevated among individuals receiving anticoagulants or antiplatelet therapy. Caution should be exercised in co-prescribing SRIs with antithrombotic therapy due to safety concerns regarding bleeding risks.

ANNALS OF MEDICINE (2022)

Add to Collection

Article Economics

POSC204 Drug-Drug Interaction Databases: Sensitivity and Specificity to Detect Manifest Drug-Drug Interactions, Reliability Ratings and Management Strategies of Potential Drug-Drug Interactions

Z Očovská et al.

VALUE IN HEALTH (2022)

Add to Collection

Article Pharmacology & Pharmacy

Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients

Arthur T. M. Wasylewicz et al.

Summary: This study compares the clinical utility of contextualized and basic DDI management in hospitalized patients. The results show that contextualized DDI management has higher positive predictive value and number of pharmacy interventions, and no DDIs were missed, indicating that it is able to better capture relevant alerts while reducing irrelevant DDI alerts.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Drug interaction alerts in older primary care patients, and related medically justified actions

Carina Tukukino et al.

Summary: This study described the interaction alerts in older patients and evaluated whether these alerts required further medical action or had already been addressed. The results showed that most alerts had already been addressed or were not relevant in the clinical setting, but some patients still needed medical action.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Add to Collection

Editorial Material Geriatrics & Gerontology

The Ambiguous Reality of Prescribing in Geriatric Practice

Philip D. Sloane et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2022)

Add to Collection

Article Pharmacology & Pharmacy

Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals

Emily K. Acton et al.

Summary: Growing evidence suggests that drug interactions may be responsible for the association between opioid use and unintentional traumatic injury. Using high-throughput screening of US commercial health insurance data, signals of opioid interactions with commonly co-dispensed medications leading to unintentional traumatic injury were identified.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions

Rostam Osanlou et al.

Summary: This study examines the burden and cost of adverse drug reactions (ADRs), polypharmacy, and multimorbidity. The researchers find that ADRs contribute to a significant number of hospital admissions, with polypharmacy and multimorbidity being important factors. They suggest that reducing inappropriate polypharmacy should be prioritized to prevent ADRs.

BMJ OPEN (2022)

Add to Collection

Article Pharmacology & Pharmacy

Drug-Related Hospital Admissions via the Department of Emergency Medicine: A Cross-Sectional Study From the Czech Republic

Zuzana Ocovska et al.

Summary: This study investigated the prevalence, preventability, and medication classes involved in drug-related hospital admissions (DRAs). The findings showed that DRAs are a significant cause of hospital admissions, with both prescribing and patient-related issues contributing to preventability. The most common medication classes associated with DRAs included antithrombotic agents, diuretics, and drugs used in diabetes. It is essential to balance the benefits and risks of medications in managing DRAs.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Adverse drug reactions and correlations with drug-drug interactions: A retrospective study of reports from 2011 to 2020

Huaqiao Jiang et al.

Summary: This study analyzed the pattern of adverse drug reactions (ADRs) in detail and obtained clinical evidence about ADRs associated with actual drug-drug interactions (DDIs). Antimicrobial agents were the most common implicated pharmacological group, with the gastrointestinal system being the most frequently affected.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Geriatrics & Gerontology

Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients)

Hannah De Schutter et al.

Summary: The purpose of this study was to update and validate the cardiovascular segment of the RASP list, a screening tool for optimizing geriatric polypharmacy. The study involved three steps, including updating the tool based on literature and expert input, internal discussions with cardiologists and pharmacists, and a Delphi consensus method with the input of various healthcare professionals. The final construct of the RASP_CARDIO list includes 95 statements related to potentially inappropriate prescribing of cardiovascular agents.

EUROPEAN GERIATRIC MEDICINE (2022)

Add to Collection

Article Geriatrics & Gerontology

Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study

John E. Hughes et al.

Summary: This study revealed a high prevalence of severe cardiovascular and CNS drug-drug interactions among older community-dwellers in Ireland, with polypharmacy and depression significantly increasing the risk of such interactions.

DRUGS & AGING (2021)

Add to Collection

Article Pharmacology & Pharmacy

Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database

Lara Magro et al.

Summary: The study found that about one-third of patients exposed to potential drug-drug interactions actually experienced serious adverse drug reactions, and that a spontaneous reporting database can be used to identify and describe ADRs caused by drug-drug interactions. Among these ADRs, warfarin was the most frequently reported interacting drug and the most common ADRs were gastrointestinal or cerebral hemorrhagic events.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease

Dharam J. Kumbhani et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Geriatrics & Gerontology

Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial

Lorene Zerah et al.

Summary: DDIs are highly prevalent in older patients, with their prevalence increasing during hospitalization and then remaining stable over time; hyperpolypharmacy is the main factor predictive of changes in DDIs.

BMC GERIATRICS (2021)

Add to Collection

Article Geriatrics & Gerontology

Ghent Older People's Prescriptions Community Pharmacy Screening (GheOP3S)-Tool Version 2: Update of a Tool to Detect Drug-Related Problems in Older People in Primary Care

Katrien Foubert et al.

Summary: The GheOP(3)S-criteria were revised and updated based on experts' agreement on their clinical relevance and recent scientific evidence. The updated tool now consists of 64 criteria, including new lists of DRPs and medications to be avoided in older people with reduced renal function. Future studies should explore the impact of pharmacist-led medication reviews using GheOP(3)S-tool version 2 on primary care outcomes.

DRUGS & AGING (2021)

Add to Collection

Article Geriatrics & Gerontology

An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People

Pauline Anrys et al.

Summary: This study aimed to establish an explicit list of potentially clinically significant drug-drug interactions (DDIs) in individuals aged over 65 years. Through a multidisciplinary expert panel and a Delphi survey, consensus was achieved on 66 potentially clinically significant DDIs, most of which involved cardiovascular, antithrombotic, and central nervous system drugs. The final list includes information on the mechanism of interaction, harm, and management, with treatment modification recommended for three-quarters of DDIs.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

Add to Collection

Article Pharmacology & Pharmacy

Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic

Martina Marikova et al.

Summary: This study aimed to investigate hospital admissions related to ADEs in geriatric patients, revealing a prevalence rate of 11.75% with antithrombotic agents and diuretics being the most common medications involved. Electrolyte disturbances and gastrointestinal haemorrhages and ulcerations were frequently observed ADEs. Out of the identified ADE-related admissions, 53.5% were considered potentially preventable.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)

Add to Collection

Article Pharmacology & Pharmacy

CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study

Katja S. Just et al.

Summary: This study identified an association between CYP2D6 activity and drug-related dizziness symptoms, particularly in relation to vigilance-related CNS symptoms. Patients with low CYP2D6 activity may be more susceptible to drug-related dizziness, highlighting the importance of understanding individual drug metabolism activity and ADR risks.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Coprescription of Opioids With Other Medications and Risk of Opioid Overdose

Nazleen F. Khan et al.

Summary: The study identified nonopioid medications such as Baclofen, lorazepam, and gabapentin that were associated with an increased risk of opioid overdose in patients taking prescription opioids. Safer alternatives should be considered when interactions are present to reduce the risk of overdose.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Pharmacology & Pharmacy

EACPT Virtual Meeting 2021

Markus Zeitlinger

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Add to Collection

Article Health Care Sciences & Services

Designing and evaluating contextualized drug-drug interaction algorithms

Eric Chou et al.

Summary: The study aims to develop, validate, and test DDI alert algorithms that utilize patient context available in electronic health records data. Synthetic health records data was used for validation and real-world hospital data was used for testing, showing the potential of the algorithms to significantly reduce alert interruptions in clinical workflow. The 8 DDI algorithms developed in the study are a step towards addressing the critical need for DDI alerts that are more specific to patient context than current commercial alerting systems.

JAMIA OPEN (2021)

Add to Collection

Article Pharmacology & Pharmacy

Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study

Yan Li et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Cell Biology

Risk of hospitalization from drug-drug interactions in the Elderly: realworld evidence in a large administrative database

Floor Swart et al.

AGING-US (2020)

Add to Collection

Article Medicine, Research & Experimental

Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury

Charles E. Leonard et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Article Geriatrics & Gerontology

American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

Donna M. Fick et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)

Add to Collection

Article Geriatrics & Gerontology

Assessing the Scope and Appropriateness of Prescribing Cascades

Lisa M. McCarthy et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)

Add to Collection

Editorial Material Medicine, General & Internal

Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI

Shamir R. Mehta

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Comparison of Self-controlled Designs for Evaluating Outcomes of Drug-Drug Interactions Simulation Study

Katsiaryna Bykov et al.

EPIDEMIOLOGY (2019)

Add to Collection

Review Pharmacology & Pharmacy

Development of a standardized chart review method to identify drug-related hospital admissions in older people

Stefanie Thevelin et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals

Nibu Parameswaran Nair et al.

DRUG SAFETY (2017)

Add to Collection

Review Pharmacology & Pharmacy

Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study

A. Marino et al.

EXPERT OPINION ON DRUG SAFETY (2016)

Add to Collection

Article Medicine, General & Internal

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010

Bruce Guthrie et al.

BMC MEDICINE (2015)

Add to Collection

Article Medicine, General & Internal

Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

Siobhan Dumbreck et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Add to Collection

Article Medicine, General & Internal

Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

Siobhan Dumbreck et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis

Supinya Dechanont et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)

Add to Collection

Review Pharmacology & Pharmacy

Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions

Lara Magro et al.

EXPERT OPINION ON DRUG SAFETY (2012)

Add to Collection

Review Geriatrics & Gerontology

Potentially Harmful Drug-Drug Interactions in the Elderly: A Review

Lisa E. Hines et al.

AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2011)

Add to Collection

Article Medicine, General & Internal

Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff

Munir Pirmohamed

WIENER KLINISCHE WOCHENSCHRIFT (2010)

Add to Collection

Article Pharmacology & Pharmacy

Admissions to a medical intensive care unit related to adverse drug reactions

Anastasia Rivkin

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)

Add to Collection

Review Multidisciplinary Sciences

Moving towards individualized medicine with pharmacogenomics

WE Evans et al.

NATURE (2004)

Add to Collection

Article Emergency Medicine

Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department

CM Hohl et al.

ANNALS OF EMERGENCY MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.